Recombinant Anti-Kit x Anti-VCAM-1 Bispecific Antibody (IgG(L)-scFv) (IGLFV-179)

Recombinant Anti-Kit x Anti-VCAM-1 Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-Kit antibody are fused to the C terminus of an anti-VCAM-1 IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can retarget hematopoietic stem cells toinjured myocardium. It is designed for the research of Cardiovascular disease therapy.

Datasheet INQUIRY

Specifications

Targets

Kit & VCAM-1

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Cardiovascular disease

Targets

Target 1

Kit

Gene ID

3815

UniProt ID

A0A024RDA0

Alternative Names

W; Bs; Fdc; Ssm; SCO1; SCO5; SOW3; CD117; c-KIT; Tr-kit; Gsfsco1; Gsfsco5; Gsfsow3; KIT proto-oncogene receptor tyrosine kinase; KIT

Target 2

VCAM-1

Gene ID

7412

UniProt ID

P19320

Alternative Names

CD106, INCAM-100; Vascular cell adhesion molecule-1; VCAM-1; vascular cell adhesion protein 1

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-Kit x Anti-VCAM-1 Bispecific Antibody (IgG(L)-scFv) (IGLFV-179). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-Kit x Anti-VCAM-1 Bispecific Antibody (IgG(L)-scFv) (CAT#: IGLFV-179)

Specifications

Targets

Customer Reviews and Q&As